131 related articles for article (PubMed ID: 24998423)
1. Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival.
Balkan II; Aygün G; Aydın S; Mutcalı SI; Kara Z; Kuşkucu M; Midilli K; Şemen V; Aras S; Yemişen M; Mete B; Özaras R; Saltoğlu N; Tabak F; Öztürk R
Int J Infect Dis; 2014 Sep; 26():51-6. PubMed ID: 24998423
[TBL] [Abstract][Full Text] [Related]
2. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
[TBL] [Abstract][Full Text] [Related]
3. Differences in clinical outcomes of bloodstream infections caused by Klebsiella aerogenes, Klebsiella pneumoniae and Enterobacter cloacae: a multicentre cohort study.
Guedes M; Gathara D; López-Hernández I; Pérez-Crespo PMM; Pérez-Rodríguez MT; Sousa A; Plata A; Reguera-Iglesias JM; Boix-Palop L; Dietl B; Blanco JS; Castillo CA; Galán-Sánchez F; Kindelán CN; Jover-Saenz A; Aguirre JG; Alemán AA; Ciordia TM; Del Arco Jiménez A; Fernandez-Suarez J; Lopez-Cortes LE; Rodríguez-Baño J;
Ann Clin Microbiol Antimicrob; 2024 May; 23(1):42. PubMed ID: 38711045
[TBL] [Abstract][Full Text] [Related]
4. Application and clinical impact of the RESIST-4 O.K.N.V. rapid diagnostic test for carbapenemase detection in blood cultures and clinical samples.
Roth S; Berger FK; Link A; Nimmesgern A; Lepper PM; Murawski N; Bittenbring JT; Becker SL
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):423-428. PubMed ID: 32895756
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis.
Katip W; Rayanakorn A; Oberdorfer P; Taruangsri P; Nampuan T; Okonogi S
J Infect Public Health; 2024 May; 17(5):727-734. PubMed ID: 38513335
[TBL] [Abstract][Full Text] [Related]
6. The Pitt Bacteremia Score Predicts Mortality in Nonbacteremic Infections.
Henderson H; Luterbach CL; Cober E; Richter SS; Salata RA; Kalayjian RC; Watkins RR; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; Harris A; Napravnik S; Van Duin D
Clin Infect Dis; 2020 Apr; 70(9):1826-1833. PubMed ID: 31219148
[TBL] [Abstract][Full Text] [Related]
7. Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection.
Corbella L; Fernández-Ruiz M; Ruiz-Ruigómez M; Rodríguez-Goncer I; Silva JT; Hernández-Jiménez P; López-Medrano F; Lizasoain M; Villa J; Aguado JM; San-Juan R
Eur J Clin Microbiol Infect Dis; 2023 Dec; 42(12):1485-1497. PubMed ID: 37889370
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities.
Zhao S; Kennedy S; Perry MR; Wilson J; Chase-Topping M; Anderson E; Woolhouse MEJ; Lockhart M
J Hosp Infect; 2021 Apr; 110():184-193. PubMed ID: 33571557
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and clinical characteristics of Morganella morganii infections: A multicenter retrospective study.
Alsaadi A; Alghamdi AA; Akkielah L; Alanazi M; Alghamdi S; Abanamy H; Aljehani S; Aldibasi OS; Bosaeed M
J Infect Public Health; 2024 Mar; 17(3):430-434. PubMed ID: 38262080
[TBL] [Abstract][Full Text] [Related]
10. Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study.
Roseau-Vincenti A; Forestier E; Lanoix JP; Ricard C; Carret MC; Caraux-Paz P; Paccalin M; Gavazzi G; Roubaud-Baudron C;
Infection; 2024 Feb; 52(1):155-163. PubMed ID: 37608043
[TBL] [Abstract][Full Text] [Related]
11. Effect of antibiotic de-escalation on clinical outcomes in patients with carbapenem-resistant Enterobacteriaceae bacteremia (CRE) in the hematology-oncology setting.
Bansal N; Sachdeva N; Bhurani D; Agarwal N; Ahmed R; Mehta P; Halder R
Germs; 2023 Sep; 13(3):221-228. PubMed ID: 38146379
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of Carbapenem-Resistant
Lee SH; Kim CH; Lee HY; Park KH; Han SH
Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627706
[TBL] [Abstract][Full Text] [Related]
13. Rapid separation of very low concentrations of bacteria from blood.
Buchanan CM; Wood RL; Hoj TR; Alizadeh M; Bledsoe CG; Wood ME; McClellan DS; Blanco R; Hickey CL; Ravsten TV; Husseini GA; Robison RA; Pitt WG
J Microbiol Methods; 2017 Aug; 139():48-53. PubMed ID: 28495585
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and risk factors for neonatal bloodstream infection due to carbapenem-resistant Enterobacteriaceae: A single-centre Chinese retrospective study.
Fang P; Gao K; Yang J; Li T; Sun Q; Shan Z; Wang Y
J Glob Antimicrob Resist; 2024 Feb; 37():28-36. PubMed ID: 38412919
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia in pediatric patients with hematopoietic stem cell transplantation.
Perez P; Patiño J; Estacio M; Pino J; Manzi E; Medina D
Hematol Transfus Cell Ther; 2020; 42(1):5-11. PubMed ID: 31519531
[TBL] [Abstract][Full Text] [Related]
16. Response to Author Comments on "Clinical, microbiological characteristics and predictors of mortality in patients with carbapenemase-producing Enterobacterales blood stream infections".
Anton-Vazquez V; Evans TJ; Fernando S; Somasunderam D; David K; Melzer M; Hawkins L; Morris-Jones S; Arias M; Drazho B; Dall'Antonia M; Planche T
Infect Prev Pract; 2023 Dec; 5(4):100327. PubMed ID: 38107238
[No Abstract] [Full Text] [Related]
17. Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.
Dickstein Y; Leibovici L; Yahav D; Eliakim-Raz N; Daikos GL; Skiada A; Antoniadou A; Carmeli Y; Nutman A; Levi I; Adler A; Durante-Mangoni E; Andini R; Cavezza G; Mouton JW; Wijma RA; Theuretzbacher U; Friberg LE; Kristoffersson AN; Zusman O; Koppel F; Dishon Benattar Y; Altunin S; Paul M;
BMJ Open; 2016 Apr; 6(4):e009956. PubMed ID: 27098822
[TBL] [Abstract][Full Text] [Related]
18. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
[TBL] [Abstract][Full Text] [Related]
19. Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections.
Morrill HJ; Pogue JM; Kaye KS; LaPlante KL
Open Forum Infect Dis; 2015 Apr; 2(2):ofv050. PubMed ID: 26125030
[TBL] [Abstract][Full Text] [Related]
20. Carbapenemase-producing Enterobacteriaceae.
Doi Y; Paterson DL
Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
